High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
Top Cited Papers
- 12 May 2016
- journal article
- research article
- Published by Elsevier BV in The Lancet Diabetes & Endocrinology
- Vol. 4 (7), 577-587
- https://doi.org/10.1016/s2213-8587(16)30042-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial HypercholesterolemiaClinical Chemistry, 2005
- Phenotype of Heterozygotes for Low-Density Lipoprotein Receptor Mutations Identified in Different Background PopulationsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)The American Journal of Cardiology, 2003
- The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.JCI Insight, 1995
- Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular geneticsThe American Journal of Cardiology, 1993
- Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotypeAtherosclerosis, 1991
- Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemiaThe Lancet, 1990
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990